Anlotinib affects systemic lipid metabolism and induces lipid accumulation in human lung cancer cells

Anlotinib has demonstrated encouraging clinical outcomes in the treatment of lung cancer, soft tissue sarcoma and thyroid carcinoma. Several clinical studies have shown a relationship between anlotinib treatme...
Source: Lipids in Health and Disease - Category: Lipidology Authors: Tags: Research Source Type: research